Cardiac Biomarkers

The purpose of the book is nicely worded in the introduction: make good doctors better'. Motivate the clinicians to use biomarkers to obtain up-to-date background knowledge regarding tools they use every day clinically, such as cardiac troponin and natriuretic peptides. Biomarkers have become essential clinical tools in the early diagnosis of acute myocardial infarction and the early diagnosis of heart failure, as well as potentially helpful tools in many other indications. Beyond doubt, Cardiac BiomarkersExpert Advice for Clinicians will achieve its purpose. Cardiac BiomarkersExpert Advice for Clinicians is divided into five sections: markers of cardiac risk, markers of cardiac ischaemia, natriuretic peptides for heart failure, biomarkers in cardio-renal disease, and looking into the future. The book combines an update on established markers and established indications, as well as a detailed discussion of markers that are considered more experimental and may still have some way togo to become clinically useful, such as, the OxPL/apoB assay, the kidney injury markers, Galactin-3, ST2, and others. The chapters are written by world experts in their fields and often co-authored by local co-workers. The book is well structured and uses American textbook-style' with all its advantages and disadvantages.